WASHINGTON — The fight over Heidi Overton’s nomination for Food and Drug Commissioner is surfacing divides within the GOP over health policy and threatening to tank the party’s chances of confirming an FDA leader during the lame duck period.
The latest fault line is vaping, with current and former GOP officials at odds over Overton’s role in President Trump’s controversial push to ease access to flavored vapes. Former FDA Commissioner Marty Makary resigned after clashing with Trump over the issue, creating the opening that Overton would fill.
Former health department senior adviser Calley Means, a prominent figure in the MAHA movement, said this month that Overton wrote a policy relaxing standards for fruit-flavored vapes. Both Overton and Means worked in the White House.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Source: www.statnews.com



